PA
UTMD icon

Parallel Advisors’s Utah Medical Products UTMD Stock Holding History

Parallel Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57
Closed -$3.19K – 3700
2025
Q1 		$3.19K Buy
+57
New +$3.42K ﹤0.01% 2830
2022
Q1 		– Sell
-83
Closed -$7.63K – 3287
2021
Q4 		$8K Buy
+83
New +$8.47K ﹤0.01% 2228
2021
Q1 		– Sell
-13
Closed -$1K – 2905
2020
Q4 		$1K Sell
13
-9
-41% -$767 ﹤0.01% 2496
2020
Q3 		$2K Sell
22
-153
-87% -$12.7K ﹤0.01% 2357
2020
Q2 		$15K Buy
175
+29
+20% +$2.6K ﹤0.01% 1554
2020
Q1 		$13K Buy
+146
New +$13.6K ﹤0.01% 1504

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Parallel Advisors's UTMD Position: Q2 2025 in Review

Parallel Advisors sold out of Utah Medical Products (UTMD) in Q2 2025, closing a stake of 57 shares — an estimated $3.19K sold.

Parallel Advisors first reported a position in UTMD in Q1 2020 and held it in 6 quarters. The position peaked at $15K in Q2 2020. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.

  • Parallel Advisors reported no remaining Utah Medical Products position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 57 Utah Medical Products shares in Q2 2025, an estimated $3.19K.
  • Parallel Advisors first reported a position in Utah Medical Products in Q1 2020 and held it in 6 quarters.
  • Parallel Advisors's Utah Medical Products position peaked at $15K in Q2 2020.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.